Safety and effectiveness of nusinersen, a treatment for spinal muscular atrophy, in 524 patients: results from an interim analysis of post-marketing surveillance in Japan
.
Source: International Journal of Neuroscience - Category: Neuroscience Authors: Yosuke TachibanaRyusuke SatoHaruki MakiokaMisuzu HoshinoMingshou JinBiogen Japan, Tokyo, Japan Source Type: research